Quantitative T-wave alternans analysis for guiding medical therapy: An underexploited opportunity

Trends in Cardiovascular Medicine

Volumn 25, Issue 3, 2015, Pages 201-213

  Verrier, Richard L ^a   Malik, Marek ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT;

ACUTE CORONARY SYNDROME; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROARRHYTHMIA; HUMAN; METHODOLOGY; MODIFIED MOVING AVERAGE METHOD; MORPHOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; ST SEGMENT; SUDDEN CARDIAC DEATH; T WAVE; T WAVE ALTERNANS; THERAPY; UNITED STATES; DEATH, SUDDEN, CARDIAC; HEART STROKE VOLUME; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT;

DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; RISK ASSESSMENT; STROKE VOLUME;

EID: 84925236363     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.10.006     Document Type: Review

References (90)

1. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 2001, 345:1473-1482.
2. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J., et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129:e28-e292.
3. Verrier R.L., Klingenheben T., Malik M., El-Sherif N., Exner D., Hohnloser S., et al. Microvolt T-wave alternans: physiologic basis, methods of measurement, and clinical utility. Consensus guideline by the International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol 2011, 44:1309-1324.
4. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006, 48:e247-e346.
5. Verrier R.L., Nieminen T. T-wave alternans as a therapeutic marker for antiarrhythmic agents. J Cardiovasc Pharmacol 2010, 55:544-554.
6. Cutler M.J., Rosenbaum D.S. Explaining the clinical manifestations of T wave alternans in patients at risk for sudden cardiac death. Heart Rhythm 2009, 6:S22-S28.
7. Verrier R.L., Kumar K., Nearing B.D. Basis for sudden cardiac death prediction by T-wave alternans from an integrative physiology perspective. Heart Rhythm 2009, 6:416-422.
8. Weiss J.N., Nivala M., Garfinkel A., Qu Z. Alternans and arrhythmias: from cell to heart. Circ Res 2011, 108:98-112.
9. Nearing B.D., Verrier R.L. Tracking heightened cardiac electrical instability by computing interlead heterogeneity of T-wave morphology. J Appl Physiol 2003, 95:2265-2272.
10. Clusin W.T. Mechanisms of calcium transient and action potential alternans in cardiac cells and tissues. Am J Physiol Heart Circ Physiol 2008, 294:H1-H10.
11. Konta T., Ikeda K., Yamaki M., Nakamura K., Honma K., Kubota I., et al. Significance of discordant ST alternans in ventricular fibrillation. Circulation 1990, 82:2185-2189.
12. Nearing B.D., Huang A.H., Verrier R.L. Dynamic tracking of cardiac vulnerability by complex demodulation of the T-wave. Science 1991, 252:437-440.
13. Nearing B.D., Oesterle S.N., Verrier R.L. Quantification of ischaemia-induced vulnerability by precordial T-wave alternans analysis in dog and human. Cardiovasc Res 1994, 28:1440-1449.
14. Wilson L.D., Jeyaraj D., Wan X., Hoeker G.S., Said T.H., Gittinger M., et al. Heart failure enhances susceptibility to arrhythmogenic cardiac alternans. Heart Rhythm 2009, 6:251-259.
15. Narayan S.M., Bayer J.D., Lalani G., Trayanova N.A. Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling. J Am Coll Cardiol 2008, 52:1782-1792.
16. Rosenbaum D.S., Jackson L.E., Smith J.M., Garan H., Ruskin J.N., Cohen R.J. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994, 330:235-241.
17. Kaufman E.S., Bloomfield D.M., Steinman R.C., Namerow P.B., Costantini O., Cohen R.J., et al. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006, 48:1399-1404.
18. Chow T., Kereiakes D.J., Onufer J., Woelfel A., Gursoy S., Peterson B.J., et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T-wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol 2008, 52:1607-1615.
19. Gold M.R., Ip J.H., Costantini O., Poole J.E., McNulty S., Mark D.B., et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 2008, 118:2022-2028.
20. Hohnloser S.H., Ikeda T., Cohen R.J. Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 2009, 6:S36-S44.
21. Chan P.S., Gold M.R., Nallamothu B.K. Do beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol 2010, 21:1009-1014.
22. Nearing B.D., Verrier R.L. Modified moving average method for T-wave alternans analysis with high accuracy to predict ventricular fibrillation. J Appl Physiol 2002, 92:541-549.
23. Leino J., Verrier R.L., Minkkinen M., Lehtimäki T., Viik J., Lehtinen R., et al. Importance of regional specificity of T-wave alternans in assessing risk for cardiovascular mortality and sudden cardiac death during routine exercise testing. Heart Rhythm 2011, 8:385-390.
24. Verrier R.L., Josephson M.E. Impact of sleep on arrhythmogenesis. Circ Arrhythm Electrophysiol 2009, 2:450-459.
25. Uchimura-Makita Y., Nakano Y., Tokuyama T., Fujiwara M., Watanabe Y., Sairaku A., et al. Time-domain T-wave alternans is strongly associated with a history of ventricular fibrillation in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2014, 25:1021-1027.
26. Takasugi N., Nishigaki K., Kubota T., Tsuchiya K., Natsuyama K., Takasugi M., et al. Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure. Eur J Heart Fail 2009, 11:1063-1070.
27. Yamada S., Suzuki H., Kamioka M., Suzuki S., Kamiyama Y., Yoshihisa A., et al. Sleep-disordered breathing increases risk for fatal ventricular arrhythmias in patients with chronic heart failure. Circ J 2013, 77:1466-1473.
28. Strzelczyk A., Adjei P., Scott C.A., Bauer S., Rosenow F., Walker M.C., et al. Postictal increase in T-wave alternans after generalized tonic-clonic seizures. Epilepsia 2011, 52:2112-2117.
29. Schomer AC, Nearing BD, Schachter SC, Verrier RL. Vagus nerve stimulation reduces cardiac electrical instability assessed by quantitative T-wave alternans analysis in patients with drug-resistant focal epilepsy. Epilepsia, in press. http://dx.doi.org/10.1111/epi.12855.
30. Secemsky E.A., Verrier R.L., Cooke G., Ghossein C., Subacius H., Manuchehry A., et al. High prevalence of cardiac autonomic dysfunction and T-wave alternans in dialysis patients. Heart Rhythm 2011, 8:592-598.
31. Makarov L., Komoliatova V. Microvolt T-wave alternans during Holter monitoring in children and adolescents. Ann Noninvasive Electrocardiol 2010, 15:138-144.
32. Exner D.V., Kavanagh K.M., Slawnych M.P., Mitchell L.B., Ramadan D., Aggarwal S.G., et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 2007, 50:2275-2284.
33. Slawnych M.P., Nieminen T., Kahonen M., Kavanagh K.M., Lehtimäki T., Ramadan D., et al. Postexercise assessment of cardiac repolarization alternans in patients with coronary artery disease using the modified moving average method. J Am Coll Cardiol 2009, 53:1130-1137.
34. Gehi A.K., Stein R.H., Metz L.D., Gomes J.A. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 2005, 46:75-82.
35. Sakaki K., Ikeda T., Miwa Y., Miyakoshi M., Abe A., Tsukada T., et al. Time-domain T-wave alternans measured from Holter electrocardiograms predicts cardiac mortality in patients with left ventricular dysfunction: a prospective study. Heart Rhythm 2009, 6:332-337.
36. Sulimov V., Okisheva E., Tsaregorodtsev D. Non-invasive risk stratification for sudden cardiac death by heart rate turbulence and microvolt T wave alternans in patients after myocardial infarction. Europace 2012, 14:1786-1792.
37. Gorodeski E.Z., Cantillon D.J., Goel S.S., Kaufman E.S., Martin D.O., Hsich E.M., et al. Microvolt T-wave alternans, peak oxygen consumption, and outcome in patients with severely impaired left ventricular systolic function. J Heart Lung Transplant 2009, 28:689-696.
38. Leino J., Minkkinen M., Nieminen T., Lehtimäki T., Viik J., Lehtinen R., et al. Combined assessment of heart rate recovery and T-wave alternans during routine exercise testing improves prediction of total and cardiovascular mortality: the Finnish Cardiovascular Study. Heart Rhythm 2009, 6:1765-1771.
39. Huikuri H.V., Raatikainen M.J., Moerch-Joergensen R., Hartikainen J., Virtanen V., Boland J., et al. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J 2009, 30:689-698.
40. Buxton A.E. Risk stratification for sudden death in patients with coronary artery disease. Heart Rhythm 2009, 6:836-847.
41. Arisha M.M., Girerd N., Chauveau S., Bresson D., Scridon A., Bonnefoy E., et al. In-hospital heart rate turbulence and microvolt T-wave alternans abnormalities for prediction of early life-threatening ventricular arrhythmia after acute myocardial infarction. Ann Noninvasive Electrocardiol 2013, 18:530-537.
42. Ikeda T., Sakata T., Takami M., Kondo N., Tezuka N., Nakae T, et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 2000, 35:722-730.
43. Fishman G.I., Chugh S.S., DiMarco J.P., Albert C.M., Anderson M.E., Bonow R.O., et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society workshop. Circulation 2010, 122:2335-2348.
44. Royston P., Altman D.G., Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006, 25:127-141.
45. Verrier R.L., Ikeda T. Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications. Prog Cardiovasc Dis 2013, 56:172-185.
46. Sakabe K., Ikeda T., Sakata T., Kawase A., Kumagai K., Tezuka N., et al. Predicting the recurrence of ventricular tachyarrhythmias from T-wave alternans assessed on antiarrhythmic pharmacotherapy: a prospective study in patients with dilated cardiomyopathy. Ann Noninvasive Electrocardiol 2001, 6:203-208.
47. Antzelevitch C., Burashnikov A., Sicouri S., Belardinelli L. Electrophysiologic basis for the antiarrhythmic actions of ranolazine. Heart Rhythm 2011, 8:1281-1290.
48. Belardinelli L., Liu G., Smith-Maxwell C., Wang W.Q., El-Bizri N., Hirakawa R., et al. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. J Pharmacol Exp Ther 2013, 344:23-32.
49. Maier L.S., Sossalla S. The late Na current as a therapeutic target: where are we?. J Mol Cell Cardiol 2013, 61:44-50.
50. Nieminen T., Nanbu D.Y., Datti I.P., Vaz G.R., Tavares C.A.M., Pegler J.R.M., et al. Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model. Heart Rhythm 2011, 8:608-614.
51. Bonatti R., Garcia Silva A.F., Pereira Batatinha J.A., Sobrado L.F., Machado A.D., Varone B.B., et al. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity. Heart Rhythm 2014, 11:1827-1835.
52. Echt D.S., Liebson P.R., Mitchell L.B., Peters R.W., Obias-Manno D., Barker A.H., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991, 324:781-788.
53. Scirica B.M., Braunwald E., Belardinelli L., Hedgepeth C.M., Spinar J., Wang W., et al. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN TIMI-36) randomized controlled trial. Circulation 2010, 122:455-462.
54. Nieminen T., Scirica B.M., Pegler J.R.M., Tavares C., Pagotto V.P.F., Kanas A.F., et al. Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo. Am J Cardiol 2014, 114:17-23.
55. Olsson G., Wikstrand J., Warnold I., Manger Cats V., McBoyle D., Herlitz J., et al. Metoprolol-induced reduction in postinfarction mortality: pooled results from five doubleblind randomized trials. Eur Heart J 1992, 13:28-32.
56. Klingenheben T., Gronefeld G., Li Y.G., Hohnloser S.H. Effect of metoprolol and d,lsotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J Am Coll Cardiol 2001, 38:2013-2019.
57. Rashba E.J., Cooklin M., Macmurdy K., Kavesh N., Kirk M., Sarang S., et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 2002, 105:837-842.
58. Komiya N., Seto S., Nakao K., Yano K. The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia. PACE 2005, 28:680-684.
59. Murata M., Harada M., Shimizu A., Kubo M., Mitani R., Dairaku Y., et al. Effect of long-term beta-blocker therapy on microvolt-level T-wave alternans in association with the improvement of the cardiac sympathetic nervous system and systolic function in patients with nonischemic heart disease. Circ J 2003, 67:821-825.
60. Multicenter Diltiazem Postinfarction Trial Research Group The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988, 319:385-392.
61. Nearing B.D., Hutter J.J., Verrier R.L. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in canines: comparison to diltiazem. J Cardiovasc Pharmacol 1996, 27:777-787.
62. Shimada H., Nishizaki M., Fujii H., Yamawake N., Fukamizu S., Sakurada H., et al. Ambulatory electrocardiogram-based T-wave alternans in patients with vasospastic angina during asymptomatic periods. Am J Cardiol 2012, 110:1446-1451.
63. Hohnloser S.H. Macroscopic T wave alternans as a harbinger of sudden death. J Cardiovasc Electrophysiol 1999, 10:625.
64. Drew B.J., Ackerman M.J., Funk M., Gibler W.B., Kligfield P., Menon V., et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010, 55:934-947.
65. Waldo A.L., Camm A.J., deRuyter H., Friedman P.L., MacNeil D.J., Pauls J.F., et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Survival with oral d-Sotalol. Lancet 1996, 348:7-12.
66. Scirica B.M. Acute coronary syndrome: emerging tools for diagnosis and risk assessment. J Am Coll Cardiol 2010, 55:1403-1415.
67. Takasugi N., Kubota T., Nishigaki K., Verrier R.L., Kawasaki M., Takasugi M., et al. Continuous T-wave alternans monitoring to predict impending life-threatening cardiac arrhythmias during emergent coronary reperfusion therapy in patients with acute coronary syndrome. Europace 2011, 13:708-715.
68. Groh W.J., Shinn T.S., Engelstein E.E., Zipes D.P. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1999, 10:1335-1339.
69. Verrier R.L., Nearing B.D., Ghanem R.N., Olson R.E., Garberich R.F., Katsiyiannis W.T., et al. Elevated T-wave alternans predicts nonsustained ventricular tachycardia in association with percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients. J Cardiovasc Electrophysiol 2013, 24:658-663.
70. Kentta T., Tulppo M.P., Nearing B.D., Karjalainen J.J., Hautala A.J., Kivinifemi A.M., et al. Effects of exercise rehabilitation on cardiac electrical instability assessed by T-wave alternans during ambulatory electrocardiogram monitoring in coronary artery disease patients without and with diabetes mellitus. Am J Cardiol 2014, 114:832-837.
71. Adam D.R., Smith J.M., Akselrod S., Nyberg S., Powell A.O., Cohen R.J. Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol 1984, 17:209-218.
72. Kovach J.A., Nearing B.D., Verrier R.L. An angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines. J Am Coll Cardiol 2001, 37:1719-1725.
73. Kop W.J., Krantz D.S., Nearing B.D., Gottdiener J.S., Quigley J.F., O[U+05F3]Callahan M., et al. Effects of acute mental and exercise stress on T-wave alternans in patients with implantable cardioverter defibrillators and controls. Circulation 2004, 109:1864-1869.
74. Lampert R., Shusterman V., Burg M., McPherson C., Batsford W., Goldberg A., et al. Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009, 53:774-778.
75. Smith J.M., Clancy E.A., Valeri C.R., Ruskin J.N., Cohen R.J. Electrical alternans and cardiac electrical instability. Circulation 1988, 77:110-121.
76. Nearing B.D., Wellenius G.A., Mittleman M.A., Josephson M.E., Burger A.J., Verrier R.L. Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure. Circ Arrhythm Electrophysiol 2012, 5:84-90.
77. Schwartz P.J., Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J 1975, 89:45-50.
78. Schwartz P.J., Motolese M., Pollavini G., Lotto A., Ruberti U., Trazzi R., et al. Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J Cardiovasc Electrophysiol 1992, 3:2-16.
79. Schwartz P.J. Cutting nerves and saving lives. Heart Rhythm 2009, 6:760-763.
80. Verrier R.L., Nearing B.D. Electrophysiologic basis for T-wave alternans as an index of vulnerability to ventricular fibrillation. J Cardiovasc Electrophysiol 1994, 5:445-461.
81. Annegers J.F., Coan S.P., Hauser W.A., Leestma J. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death. Epilepsia 2000, 41:549-553.
82. Hashimoto H., Suzuki K., Miyake S., Nakashima M. Effects of calcium antagonists on the electrical alternans of the ST segment and on associated mechanical alternans during acute coronary occlusion in dogs. Circulation 1983, 68:667-672.
83. Murdock D., Kaliebe J., Overton N. Ranolazine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report. PACE 2008, 31:765-768.
84. Verrier R.L., Nearing B.D., LaRovere M.T., Pinna G.D., Mittleman M.A., Bigger J.T., et al. Ambulatory ECG-based tracking of T-wave alternans in post-myocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 2003, 14:705-711.
85. Stein P.K., Sanghavi D., Domitrovich P.P., Mackey R.A., Deedwania P. Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study. J Cardiovasc Electrophysiol 2008, 19:1037-1042.
86. Maeda S., Nishizaki M., Yamawake N., Ashikaga T., Shimada H., Asano M., et al. Ambulatory ECG-based T-wave alternans and heart rate turbulence predict high risk of arrhythmic events in patients with old myocardial infarction. Circ J 2009, 73:2223-2228.
87. Stein P.K., Sanghavi D., Sotoodehnia N., Siscovick D.S., Gottdiener J. Association of Holter-based measures including T-wave alternans with risk of sudden cardiac death in the community-dwelling elderly: the Cardiovascular Health Study. J Electrocardiol 2010, 43:251-259.
88. Hoshida K., Miwa Y., Miyakoshi M., Tsukada T., Yusu S., Yoshino H, et al. Simultaneous assessment of T-wave alternans and heart rate turbulence on Holter electrocardiograms as predictors for serious cardiac events in patients after myocardial infarction. Circ J 2013, 77:432-438.
89. Ren L.-N., Fang X.H., Ren L.D., Gong J., Wang Yq, Qi G-x, et al. Ambulatory ECG-based T-wave alternans and heart rate turbulence can predict cardiac mortality in patients with myocardial infarction with or without diabetes mellitus. Cardiovasc Diabetol 2012, 11:104-111.
90. Hou Y., Fang P.H., Wu Y., Li X-f, Liu J., Li Z., et al. Prediction of sudden cardiac death in patients after acute myocardial infarction using T-wave alternans: a prospective study. J Electrocardiol 2012, 45:60-65.